A man who killed his ex-partner’s sister and her three children by setting fire to their house has been sentenced to a whole-life order. Antonia Gawith said she was “haunted” because she was the intended target of the arson attack by her former boyfriend, Sharaz Ali. “Knowing they died because someone wanted to kill me is a torment I can never put into words,” she told a sentencing hearing on Frid...
A man who killed his ex-partner’s sister and her three children by setting fire to their house has been sentenced to a whole-life order. Antonia Gawith said she was “haunted” because she was the intended target of the arson attack by her former boyfriend, Sharaz Ali. “Knowing they died because someone wanted to kill me is a torment I can never put into words,” she told a sentencing hearing on Friday. Antonia’s sister Bryonie Gawith, 29, and Bryonie’s three children – Denisty Birtle, nine, Oscar Birtle, five, and Aubree Birtle, 22 months – died in the blaze started at their home in Bradford. Ali, 40, was “motivated by jealousy and fuelled by drink and drugs” when he turned up at the house in the early hours of 21 August 2024. Antonia, who had ended an abusive seven-year relationship with Ali, managed to escape the fire but Bryonie and her three children died. View image in fullscreen Bryonie Gawith and her three children, Denisty, Oscar and Aubree. Photograph: West Yorkshire police/PA Sentencing Ali to a whole-life order – meaning he will never be released from prison – the judge, Mr Justice Hilliard, said Ali’s intention was to “wipe out a family”. He told Doncaster crown court that the three children were “acceptable collateral damage” for Ali because he was “so full of hatred for Bryonie”, whom he blamed for the breakup with Antonia. Antonia tearfully told the hearing that Bryonie’s children were “my babies, my joy”. She said: “What haunts me the most is the attack was meant for me. I was the target; petrol was poured on me and my life was meant to end that night. I can’t escape the thought that I was spared when they were taken. How can I move on when they never had the chance to?” Sobs could be heard from family members in the public gallery as Antonia said Bryonie “had warmth that could fill a room and a heart so big she would give the world away if she could”. Calum Sunderland, 27, a crack-cocaine addict who went with Ali to the house and kicked in the door fo...
Shuttle Pharmaceuticals ( SHPH ) has entered into a securities purchase agreement with investors for the issuance and sale of 2.24M shares of common stock and pre-funded warrants to purchase 4.76M shares of common stock, in a public offering, for aggregate gross proceeds of ~$3.50M. The offering is expected to close on or about March 9, 2026. SHPH -13.92% premarket to $0.7476. Source: Press Releas...
Shuttle Pharmaceuticals ( SHPH ) has entered into a securities purchase agreement with investors for the issuance and sale of 2.24M shares of common stock and pre-funded warrants to purchase 4.76M shares of common stock, in a public offering, for aggregate gross proceeds of ~$3.50M. The offering is expected to close on or about March 9, 2026. SHPH -13.92% premarket to $0.7476. Source: Press Release More on Shuttle Pharmaceuticals Seeking Alpha’s Quant Rating on Shuttle Pharmaceuticals Financial information for Shuttle Pharmaceuticals
Elong Power ( ELPW ) on Friday said it will implement a 1 for 80 share consolidation of its Class A and Class B ordinary shares, effective at the open of trading on Nasdaq on March 10. The reverse split was approved by the board on March 5 following shareholder authorization at an extraordinary general meeting in January. The company said the move is intended to help it maintain compliance with Na...
Elong Power ( ELPW ) on Friday said it will implement a 1 for 80 share consolidation of its Class A and Class B ordinary shares, effective at the open of trading on Nasdaq on March 10. The reverse split was approved by the board on March 5 following shareholder authorization at an extraordinary general meeting in January. The company said the move is intended to help it maintain compliance with Nasdaq listing rules requiring a minimum closing bid price above $0.10. After the consolidation, the company’s Class A shares will continue to trade under the ticker “ELPW” but with a new CUSIP number. Elong Power said its total issued and outstanding shares will decrease to about 0.79 million from roughly 63 million following the reverse split. ELPW -38.27% premarket to $0.0495. Source: Press Release More on Elong Power Holding Limited Elong Power approves 16-for-1 reverse stock split Seeking Alpha’s Quant Rating on Elong Power Holding Limited Financial information for Elong Power Holding Limited
Mariya Borisova/iStock via Getty Images Introduction Coty’s ( COTY ) earnings release last month has triggered a sharp selloff with the stock falling 25% over the last month after the company suspended its FY'26 guidance and outlined a weaker near-term outlook. On the surface, you could argue the reaction seems justified as sales remain under pressure, margins have compressed, and the Consumer Bea...
Mariya Borisova/iStock via Getty Images Introduction Coty’s ( COTY ) earnings release last month has triggered a sharp selloff with the stock falling 25% over the last month after the company suspended its FY'26 guidance and outlined a weaker near-term outlook. On the surface, you could argue the reaction seems justified as sales remain under pressure, margins have compressed, and the Consumer Beauty segment continues to face market share challenges. But in my view, I think there's several developments that suggest the situation may be more nuanced than the market initially interpreted. In this article, I’ll discuss Coty’s latest quarterly results, the factors driving the current weakness, and why I think the company’s longer-term turnaround potential might still support a more constructive view on the stock. A look at Q2'25 results Coty reported Q2 results that are largely in line with expectations with comparable revenues down 3% due to a moderating fragrance market that slowed to roughly 3% growth amid aggressive holiday promotions and poor share performance in regions like the U.S., Germany, and the U.K. On revenues of $1.68 billion , the top line beat slightly by $19 million but EPS of $0.14 missed by 4 cents . Seeking Alpha Company Filings When looking at the results by segment, Prestige net sales fell 2% on a like for like basis with innovation driving double-digit growth and reduced destocking headwinds providing some offset. In Consumer Beauty, revenues dropped 6% as persistent market share gaps in mass cosmetics weighed on results despite emerging-market strength. While macro is partly to blame, execution challenges and category weakness were also detractors. Q2’26 results (Company Filings) Despite the results relatively in line with what the sellside expected, the company’s shares reacted negatively falling 16% the following day and the market being uncertain about the outlook with FY’26 guidance suspended. Before I discuss that, there were a few positive...
gece33/E+ via Getty Images The conflict in the Middle East, which has driven fuel prices up 15–20% over the past week, could quickly affect airlines’ first-quarter financial results as the industry grapples with rising jet fuel costs and flight disruptions across the region. And the “meaningful” impact on the industry could spill into the second quarter, said United’s chief executive, Scott Kirby,...
gece33/E+ via Getty Images The conflict in the Middle East, which has driven fuel prices up 15–20% over the past week, could quickly affect airlines’ first-quarter financial results as the industry grapples with rising jet fuel costs and flight disruptions across the region. And the “meaningful” impact on the industry could spill into the second quarter, said United’s chief executive, Scott Kirby, Thursday afternoon at an event at Harvard’s John A. Paulson School of Engineering and Applied Sciences. Kirby reminded his audience that because airlines no longer hedge their fuel costs given the challenges in hedging the spread between the price of crude oil and gasoline, the volatility in the market could impact the carrier’s bottom line sooner than anticipated. Airlines have been especially exposed to the spike in fuel prices. Fuel typically represents about one-third of operating costs in normal times and can climb to over 40% during periods of geopolitical instability. Price volatility can also be harder to manage depending on the fuel’s point of origin. According to a report from Citi Research, crack spreads have moved dramatically and unevenly across geographies. Over the past week, Singapore Jet has increased more than $3 per gallon, while NY Jet is up a little over $1 per gallon. As a result, carriers like Alaska Air ( ALK ) are the most vulnerable to higher fuel prices (given its West Coast exposure), and JetBlue ( JBLU ) the least with its major hub at New York’s JFK International Airport. As carriers around the world struggle to manage one of their largest operating expenses, airline stocks continue to slide. Shares of the U.S. Global Jets ETF have fallen about 6% over the past five days and are expected to open another 3% lower on Friday. More on United Airlines United Airlines: Rare Quality At A Peer-Group Discount United Airlines' 2026 Just Got Much More Cloudy United Airlines Holdings, Inc. (UAL) Presents at Barclays 43rd Annual Industrial Select Conferenc...
U.S. Treasury bonds paid decent yields for a while, but that’s very likely to come to an end soon. This year and in 2027, retirees should prepare their portfolios for one or more interest-rate cuts. If government bond yields are poised to fall, retirement investors will probably want to get passive income from other sources. ... The NASDAQ Dividend Stocks Retirees Are Loading Up On Before the Next...
U.S. Treasury bonds paid decent yields for a while, but that’s very likely to come to an end soon. This year and in 2027, retirees should prepare their portfolios for one or more interest-rate cuts. If government bond yields are poised to fall, retirement investors will probably want to get passive income from other sources. ... The NASDAQ Dividend Stocks Retirees Are Loading Up On Before the Next Rate Cut
My top 10 things to watch Friday, March 6 1. Oil futures are jumping again on U.S.-Iran war concerns. Global benchmark Brent is at roughly $90 a barrel. U.S. crude is at nearly $87. So much for American energy self-sufficiency. Qatar's energy minister told the Financial Times that all Gulf producers may soon halt exports due to the war. No end to the number of missiles Iran seems to launch, even a...
My top 10 things to watch Friday, March 6 1. Oil futures are jumping again on U.S.-Iran war concerns. Global benchmark Brent is at roughly $90 a barrel. U.S. crude is at nearly $87. So much for American energy self-sufficiency. Qatar's energy minister told the Financial Times that all Gulf producers may soon halt exports due to the war. No end to the number of missiles Iran seems to launch, even as our military says Iran's capabilities are degraded. 2. Unsurprisingly, stock futures are under pressure this morning. The bigger the gains in oil, the harder it is for stocks to rally . An unexpected drop in February payrolls isn't helping, either. We have a market in limbo . I hate limbo, but as I told "Mad Money" viewers last night, we can't be spooked out of stocks. 3. A bright spot: Chipmaker Marvell raised its revenue growth projections for both fiscal 2027 and 2028 after a strong end to FY26. Booming data center demand. The hyperscalers all seem to take one Marvell product or another. CEO Matt Murphy gave a passionate defense of the company on "Mad Money" in December, and he was right. Shares are up 11% premarket. 4. Club name Costco reported impressive same-store sales growth last night, but its membership renewal rate in the U.S. and Canada is still under pressure. As much as I've loved Costco, that's been frustrating. Still, we nudged up our price target on the stock, as did others on the Street. Bernstein went to $1,170 from $1,155. JPMorgan went to $1,060 from $1,050. Shares aren't moving much this morning. 5. The "SaaS apocalypse" seems to be waning, which is very good news for the asset managers with investment funds that are heavily weighted toward enterprise software. Somewhat quietly, the IGV software ETF is up over 7% this week, extending a modest gain last week. This had been the epicenter of the software carnage. 6. Time to buy the stock of Tapestry , the owner of the Coach and Kate Spade brands. Yesterday, I caught up with CEO Joanne Crevoiserat , and ...
CN Energy Group ( CNEY ) regained compliance with Nasdaq’s minimum bid price rule. The company will remain under a one-year discretionary monitoring period by Nasdaq. More on Cn Energy Group CN Energy receives Nasdaq notification Seeking Alpha’s Quant Rating on Cn Energy Group Financial information for Cn Energy Group
CN Energy Group ( CNEY ) regained compliance with Nasdaq’s minimum bid price rule. The company will remain under a one-year discretionary monitoring period by Nasdaq. More on Cn Energy Group CN Energy receives Nasdaq notification Seeking Alpha’s Quant Rating on Cn Energy Group Financial information for Cn Energy Group
Image source: The Motley Fool. March 6, 2026, 8:30 a.m. ET Call participants Chief Executive Officer — Meryl Golden Chief Financial Officer — Randy Patten Need a quote from a Motley Fool analyst? Email [email protected] Takeaways Net Income -- $14.8 million in the quarter, representing the highest quarterly profit in company history. -- $14.8 million in the quarter, representing the highest quarte...
Image source: The Motley Fool. March 6, 2026, 8:30 a.m. ET Call participants Chief Executive Officer — Meryl Golden Chief Financial Officer — Randy Patten Need a quote from a Motley Fool analyst? Email [email protected] Takeaways Net Income -- $14.8 million in the quarter, representing the highest quarterly profit in company history. -- $14.8 million in the quarter, representing the highest quarterly profit in company history. Diluted Earnings per Share -- $1.30 for the quarter and $2.88 for the year, increasing 95% year over year. -- $1.30 for the quarter and $2.88 for the year, increasing 95% year over year. Return on Equity -- 51% annualized for the quarter and 43% for the year, each up significantly from prior periods. -- 51% annualized for the quarter and 43% for the year, each up significantly from prior periods. Direct Premiums Written -- $82.8 million for the quarter (up 14%) and $277.8 million for the year (up 15%), with 39% growth since year-end 2023. -- $82.8 million for the quarter (up 14%) and $277.8 million for the year (up 15%), with 39% growth since year-end 2023. Combined Ratio -- 64.2% GAAP net combined ratio in the quarter, with a 75% full-year ratio, driven by a 1.2-point catastrophe loss ratio, materially lower than the six-year average of 7.1 points. -- 64.2% GAAP net combined ratio in the quarter, with a 75% full-year ratio, driven by a 1.2-point catastrophe loss ratio, materially lower than the six-year average of 7.1 points. Net Premiums Earned -- Increased 38% in the quarter and 46% for the year, attributed primarily to quota share reductions. -- Increased 38% in the quarter and 46% for the year, attributed primarily to quota share reductions. Underlying Loss Ratio -- Improved to 34.7% for the quarter and 44.4% for the year, aided by better risk selection through the Select product. -- Improved to 34.7% for the quarter and 44.4% for the year, aided by better risk selection through the Select product. Expense Ratio -- 30% for the year, impro...
Solid Biosciences ( SLDB ) has entered into a securities purchase agreement with a select group of institutional accredited investors for an ~$240 million private placement. The company is selling 14.97M shares of common stock at a price of $5.61 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 27.80M shares of common stock at a price of $5.6...
Solid Biosciences ( SLDB ) has entered into a securities purchase agreement with a select group of institutional accredited investors for an ~$240 million private placement. The company is selling 14.97M shares of common stock at a price of $5.61 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 27.80M shares of common stock at a price of $5.609 per pre-funded warrant. Each pre-funded warrant will have an exercise price of $0.001 per share, will be exercisable immediately, and will be exercisable until exercised in full. The private placement is being conducted in accordance with applicable Nasdaq rules and was priced to satisfy the “Minimum Price” requirement. It is expected to close on or about March 9, 2026. The company expects to use net proceeds from the private placement to fund ongoing pipeline development programs, business development activities, and for working capital and other general corporate purposes. SLDB +10.87% premarket to $6.22. Source: Press Release More on Solid Biosciences Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript Solid Biosciences: Positive FDA Meeting For SGT-003 Sets Up Next Milestones Solid Biosciences Inc. (SLDB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Solid Bio aligns with FDA on late-stage trial design for Duchenne drug Solid Bio rises as Duchenne study gets fully enrolled
Jeremy Poland/iStock via Getty Images We present our note on OKLO, a nuclear energy company, with a Sell rating. We are constructive on the nuclear renaissance and the rise of small modular reactors amid growing demand for clean baseload power, and we find OKLO and its reactor design promising. However, we believe the company is priced beyond perfection, driven by investor hype, and even if it is ...
Jeremy Poland/iStock via Getty Images We present our note on OKLO, a nuclear energy company, with a Sell rating. We are constructive on the nuclear renaissance and the rise of small modular reactors amid growing demand for clean baseload power, and we find OKLO and its reactor design promising. However, we believe the company is priced beyond perfection, driven by investor hype, and even if it is successful in gaining regulatory approval and achieving commercial adoption, the stock is still likely to underperform going forward. While we appreciate the company’s extensive pipeline and deals with hyperscalers, we are not convinced by the owner-operator model OKLO has chosen, given its higher capital intensity and risks. We also note HALEU supply-chain bottlenecks as a key constraint for the company in the foreseeable future. We prefer other names that offer more attractive exposure to the nuclear theme with better risk/reward profiles. In this note, we provide a brief introduction to the company, review the business model and its key constraints, outline our valuation and investment case, and discuss the key risks. Introduction To OKLO OKLO is a nuclear technology company based in Santa Clara, California, co-founded in 2013 by Jacob and Caroline DeWitte, currently serving as CEO and COO, respectively. Named after the eponymous Oklo region in Gabon, where several natural nuclear fission reactors were discovered, the company aims to develop fast small modular reactors. OKLO’s main design is the Aurora Powerhouse, a fast fission reactor that can produce up to 75 MWe of electrical power. The company was previously chaired by one of its most prominent backers, OpenAI CEO Sam Altman , who stepped down from his role earlier last year to avoid potential future conflicts of interest and pave the way for collaborations between the two companies in the future. OKLO is listed on the NYSE under the ticker OKLO and has a market capitalization of nearly $10.3 billion. Oklo SPAC Pres...
lucky-photographer Wedbush ( IVES ) said it remains Outperform-rated on AppLovin ( APP ) as the company is aggressively transforming from a mobile gaming ad network into a broad, AI-driven performance marketing ecosystem. The firm kept its $640 price target on the stock. Shares of AppLovin fell about 3% premarket on Friday. Analysts led by Alicia Reese said they hosted a call with AppLovin to disc...
lucky-photographer Wedbush ( IVES ) said it remains Outperform-rated on AppLovin ( APP ) as the company is aggressively transforming from a mobile gaming ad network into a broad, AI-driven performance marketing ecosystem. The firm kept its $640 price target on the stock. Shares of AppLovin fell about 3% premarket on Friday. Analysts led by Alicia Reese said they hosted a call with AppLovin to discuss the technology roadmap, the e-commerce expansion, and the competitive landscape. The analysts noted that with the foundational success of AppLovin's advertising platform AXON 2.0 already established, the immediate catalyst is the aggressive scaling of their e-commerce self-service platform and the rollout of new GenAI-driven advertising tech. "As they move toward general availability of the e-commerce product, highlighted by the upcoming launch of 30-60s AI video ads and dynamic product catalogs, AppLovin is positioned to capture a massive TAM expansion," said Reese and her team. The analysts added that, supported by a core gaming business sustaining 20% to 30% baseline growth and a highly scalable infrastructure, the company remains a cash-generation engine primed for compounding organic growth and aggressive share buybacks. On the competition front, the analysts said that some of AppLovin’s biggest competitors are also major partners. Still, when compared on effectiveness in probabilistic bidding environments (without identity), AppLovin dominates, particularly in the specific mobile gaming niche, according to the analysts. Reese and her team noted that other major competitors lack AppLovin's sophisticated buying tools, leading to lower lifetime value, or LTV, for advertisers and ultimately driving churn back to AppLovin. Smaller ad tech companies can exist in the competitive sphere but struggle to gain share from AppLovin as the industry expands, the analysts noted. On capital allocation, the analysts said that AppLovin generates significant cash flow, and with its s...
Shares of Ubiquiti, Inc. (UI 3.16%) rallied 39.1% in February, according to data from S&P Global Market Intelligence. Ubiquiti was the target of a short-seller report in late January, which may have increased short interest in the stock just before earnings. Unfortunately for those short-sellers, Ubiquiti went on to deliver a terrific earnings report, beating analyst expectations by a significant ...
Shares of Ubiquiti, Inc. (UI 3.16%) rallied 39.1% in February, according to data from S&P Global Market Intelligence. Ubiquiti was the target of a short-seller report in late January, which may have increased short interest in the stock just before earnings. Unfortunately for those short-sellers, Ubiquiti went on to deliver a terrific earnings report, beating analyst expectations by a significant amount. That beat may have forced a short squeeze, sending shares higher. Expand NYSE : UI Ubiquiti Today's Change ( -3.16 %) $ -25.21 Current Price $ 773.17 Key Data Points Market Cap $47B Day's Range $ 745.63 - $ 788.73 52wk Range $ 255.00 - $ 803.60 Volume 2 Avg Vol 103K Gross Margin 45.42 % Dividend Yield 0.39 % A small float can lead to big swings Ubiquiti is unique among public companies in that its founder and CEO, Robert Pera, owns 93% of the shares outstanding, which leaves a very small public float, even though Ubiquiti's market cap has surged to $47 billion as of this writing. At the end of January, a short-selling fund called Hunterbrook Capital disclosed it was short Ubiquiti shares. The crux of Hunterbrook's short case was that Ubiquiti equipment was being routed through distributors into Russia for use in Russia's military communications, in violation of sanctions. Then, in early February, Hunterbrook published a second piece, claiming Ubiquiti equipment was used at Jeffrey Epstein's island and Sean "P-Diddy" Combs' house. Ubiquiti makes high-performance networking gear that is easy to use and has strong privacy features, which are, of course, features all customers want -- even criminals. In addition, Ubiquiti sells to distributors worldwide, so secondary or multiple levels of resales may be hard to track. But again, these claims are coming from a motivated short-seller, and it's pretty unclear if Ubiquiti is even liable if its equipment somehow made it into the hands of bad actors. Ubiquiti has been shorted a few times in the past, but these short attacks n...
Key Points In late January, Ubiquiti attracted the attention of a short-seller. However, its December quarter earnings report blew past expectations, leading to a surge. February's move may have been augmented by a short squeeze, given the stock's low-public float. 10 stocks we like better than Ubiquiti › Shares of Ubiquiti, Inc. (NYSE: UI) rallied 39.1% in February, according to data from S&P Glo...
Key Points In late January, Ubiquiti attracted the attention of a short-seller. However, its December quarter earnings report blew past expectations, leading to a surge. February's move may have been augmented by a short squeeze, given the stock's low-public float. 10 stocks we like better than Ubiquiti › Shares of Ubiquiti, Inc. (NYSE: UI) rallied 39.1% in February, according to data from S&P Global Market Intelligence. Ubiquiti was the target of a short-seller report in late January, which may have increased short interest in the stock just before earnings. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Unfortunately for those short-sellers, Ubiquiti went on to deliver a terrific earnings report, beating analyst expectations by a significant amount. That beat may have forced a short squeeze, sending shares higher. A small float can lead to big swings Ubiquiti is unique among public companies in that its founder and CEO, Robert Pera, owns 93% of the shares outstanding, which leaves a very small public float, even though Ubiquiti's market cap has surged to $47 billion as of this writing. At the end of January, a short-selling fund called Hunterbrook Capital disclosed it was short Ubiquiti shares. The crux of Hunterbrook's short case was that Ubiquiti equipment was being routed through distributors into Russia for use in Russia's military communications, in violation of sanctions. Then, in early February, Hunterbrook published a second piece, claiming Ubiquiti equipment was used at Jeffrey Epstein's island and Sean "P-Diddy" Combs' house. Ubiquiti makes high-performance networking gear that is easy to use and has strong privacy features, which are, of course, features all customers want -- even criminals. In addition, Ubiquiti sells to distributors worldwide, so secondary or multiple levels of res...
Dream Industrial Real Estate Investment Trust ( DREUF ) announced normal course issuer bid to repurchase up to 28.27M units (10% of public float). The buyback program will start March 10, 2026 and run until March 9, 2027 The current buyback program (expiring March 9, 2026) authorized 27.80M units, of which 5.55M units were repurchased at an average price of $12.20 for about $67.7M. More on Dream I...
Dream Industrial Real Estate Investment Trust ( DREUF ) announced normal course issuer bid to repurchase up to 28.27M units (10% of public float). The buyback program will start March 10, 2026 and run until March 9, 2027 The current buyback program (expiring March 9, 2026) authorized 27.80M units, of which 5.55M units were repurchased at an average price of $12.20 for about $67.7M. More on Dream Industrial Real Estate Investment Trust Dream Industrial Real Estate Investment Trust (DIR.UN:CA) Q4 2025 Earnings Call Transcript Dream Industrial: Undervalued With Solid Growth Outlook Seeking Alpha’s Quant Rating on Dream Industrial Real Estate Investment Trust Historical earnings data for Dream Industrial Real Estate Investment Trust Dividend scorecard for Dream Industrial Real Estate Investment Trust
On February 17, 2026, Boxer Capital Management, LLC disclosed a buy of 135,000 shares of Celcuity (CELC +0.14%), an estimated $11.10 million trade based on quarterly average pricing. What Happened According to a February 17, 2026, SEC filing, Boxer Capital Management, LLC increased its stake in Celcuity by 135,000 shares during the fourth quarter of 2025. The estimated transaction value was $11.10...
On February 17, 2026, Boxer Capital Management, LLC disclosed a buy of 135,000 shares of Celcuity (CELC +0.14%), an estimated $11.10 million trade based on quarterly average pricing. What Happened According to a February 17, 2026, SEC filing, Boxer Capital Management, LLC increased its stake in Celcuity by 135,000 shares during the fourth quarter of 2025. The estimated transaction value was $11.10 million based on the average closing price for the period. As of December 31, 2025, the position’s reported value was $22.44 million, up $18.00 million from the prior quarter due to both trading activity and price changes. What Else to Know Boxer Capital added to its Celcuity position, which now represents 4.9% of the fund’s 13F reportable assets. Top holdings after the filing: NASDAQ:TNGX: $96.36 million (21.1% of AUM) NASDAQ:RVMD: $31.86 million (7.0% of AUM) NASDAQ:KOD: $31.76 million (7.0% of AUM) NASDAQ:KYMR: $25.61 million (5.6% of AUM) NASDAQ: CELC: $22.44 million (4.9% of AUM) As of February 17, 2026, Celcuity shares were priced at $107.32, up 741.1% over the past year, outperforming the S&P 500 by 721.3 percentage points. Company Overview Metric Value Price (as of market close February 17, 2026) $107.32 Market capitalization $4.97 billion Net income (TTM) ($162.72 million) One-year price change 741.1% Company Snapshot Celcuity develops molecularly targeted therapies for cancer, with key products including the CELsignia diagnostic platform and the investigational drug Gedatolisib for breast cancer treatment. The company operates a clinical-stage biotechnology business model, generating value through the development and potential commercialization of proprietary diagnostics and therapeutics, with future revenue expected from product approvals and partnerships. Primary customers are healthcare providers and oncologists treating patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer in the United States. Celcuity is a clinical...